Smoking, low density lipoprotein cholesterol, fibrinogen and myocardial infarction before 41 years of age: A Danish case-control study

被引:11
作者
von Eyben, FE
Mouritsen, E
Holm, J
Montvilas, P
Dimcevski, G
Helleberg, I
Kristensen, L
Suciu, G
von Eyben, R
机构
[1] Herning Cent Hosp, Dept Internal Med, Herning, Denmark
[2] Herning Cent Hosp, Dept Clin Chem, Herning, Denmark
[3] Herning Cent Hosp, Dept Radiol, Herning, Denmark
[4] Herning Cent Hosp, Dept Clin Physiol, Herning, Denmark
[5] Ohio State Univ, Dept Biostat, Columbus, OH 43210 USA
[6] Univ Calif Los Angeles, Acad Technol Serv, Los Angeles, CA 90024 USA
来源
JOURNAL OF CARDIOVASCULAR RISK | 2002年 / 9卷 / 03期
关键词
smoking; low density lipoprotein cholesterol; fibrinogen; myocardial infarction; case-control study; logistic regression;
D O I
10.1097/00043798-200206000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Of major coronary risk factors, smoking and total cholesterol were significant in a previous Danish case-control study of myocardial infarction at a young age. Objective To determine whether smoking was an important coronary risk factor in the context of new and major anthropometric and biochemical risk factors for myocardial infarction in individuals less than 41 years of age. Methods A prevalence hospital-based matched case-control study of young individuals. We selected 22 Caucasian cases and 24 Caucasian controls without coronary heart disease matching for age and gender and studied a series of major coronary risk factors and newer anthropometric and biochemical variables. Results In conditional univariate logistic regression analyses, the following factors were significantly associated with the coronary risk: family history, social class, smoking, intraabdominal adipose tissue area as percentage of total abdominal adipose tissue area on a CT scan, glycosylated haemoglobin level, systolic blood pressure, total cholesterol, low density lipoprotein (LDL) cholesterol, homocysteine, and fibrinogen levels (P < 0.05). However, in multiple conditional logistic regression analyses, only smoking, LDL cholesterol, and fibrinogen levels remained significant. Ten cases (46%) and none of the 24 controls were smokers with a LDL cholesterol level 4.5 mmol/l and a fibrinogen level 3.7 g/l (P = 0.0003, Fisher's exact test). Conclusion Out of a series of major and newer coronary risk factors in young Western Caucasians, smoking, and levels of LDL cholesterol, and fibrinogen were independent significant coronary risk factors. The findings need to be validated in prospective studies. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [21] The Effect of Intensified Low Density Lipoprotein Cholesterol Reduction on Recurrent Myocardial Infarction and Cardiovascular Mortality
    Huang, Wei-Chun
    Lin, Tzu-Wen
    Chiou, Kuan-Rau
    Cheng, Chin-Chang
    Kuo, Feng-Yu
    Chiang, Cheng-Hung
    Yang, Jin-Shiou
    Lin, Ko-Long
    Hsiao, Shin-Hung
    Yeh, Tong-Chen
    Mar, Guang-Yuan
    Hsiao, Hsiang-Chiang
    Lin, Shoa-Lin
    Chiou, Chuen-Wang
    Liu, Chun-Peng
    ACTA CARDIOLOGICA SINICA, 2013, 29 (05) : 404 - 412
  • [22] Relationship between smoking habits and low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, and triglycerides in a hypercholesterolemic adult cohort, in relation to gender and age
    Schuitemaker, GE
    Dinant, GJ
    van der Pol, GA
    van Wersch, JWJ
    CLINICAL AND EXPERIMENTAL MEDICINE, 2002, 2 (02) : 83 - 88
  • [23] Relationship of the Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio with a Vulnerable Plaque in Patients with Severe Carotid Artery Stenosis: A Case-Control Study in the Han Chinese Population
    Liu, Heqian
    Chen, Zhipeng
    Ding, Jiawen
    Mamateli, Subinuer
    Cai, Jing
    Qiao, Tong
    CURRENT NEUROVASCULAR RESEARCH, 2022, 19 (02) : 160 - 170
  • [24] Association Between Circulating Oxidized LDL Cholesterol Levels and Premature Myocardial Infarction: A Case-Control Study
    Rahmanian, Karamatollah
    Shojaei, Mohammad
    Hooshmand, Farhang
    Sharifi, Nader
    Rahmanian, Vahid
    HEALTH SCOPE, 2024, 13 (04):
  • [25] Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study
    Horsdal, Henriette Thisted
    Sondergaard, Flemming
    Johnsen, Soren Paaske
    Rungby, Jorgen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (04) : 331 - 337
  • [26] Calcium channel blockers and myocardial infarction: A case-control study in a Japanese hospital
    Ohyama, Y
    Funao, K
    Kawabe, E
    Hayashi, D
    Yamazaki, T
    Iga, T
    Koide, D
    Ohe, K
    Kubota, K
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (06) : 487 - 492
  • [27] Patients with low high-density lipoprotein-cholesterol or smoking are more likely to develop myocardial infarction among subjects with a visible lesion or stenosis in coronary artery
    Sun, Yu-Hua
    Yang, Yue-Jin
    Pei, Wei-Dong
    Wu, Yong-Jian
    Gao, Run-Lin
    CIRCULATION JOURNAL, 2006, 70 (12) : 1602 - 1605
  • [28] Psychosocial Stress and Risk of Myocardial Infarction: A Case-Control Study in Belgrade (Serbia)
    Vujcic, Isidora
    Vlajinac, Hristina
    Dubljanin, Eleonora
    Vasiljevic, Zorana
    Matanovic, Dragana
    Maksimovic, Jadranka
    Sipetic, Sandra
    ACTA CARDIOLOGICA SINICA, 2016, 32 (03) : 281 - 289
  • [29] Benefit of Early Statin Therapy in Patients With Acute Myocardial Infarction Who Have Extremely Low Low-Density Lipoprotein Cholesterol
    Lee, Ki Hong
    Jeong, Myung Ho
    Kim, Ha Mi
    Ahn, Youngkeun
    Kim, Jong Hyun
    Chae, Shung Chull
    Kim, Young Jo
    Hur, Seung Ho
    Seong, In Whan
    Hong, Taek Jong
    Choi, Dong Hoon
    Cho, Myeong Chan
    Kim, Chong Jin
    Seung, Ki Bae
    Chung, Wook Sung
    Jang, Yang Soo
    Rha, Seung Woon
    Bae, Jang Ho
    Cho, Jeong Gwan
    Park, Seung Jung
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (16) : 1664 - 1671
  • [30] Type D Personality and Myocardial Infarction: A Case-Control Study
    Manoj, M. T.
    Joseph, K. A.
    Vijayaraghavan, Govindan
    INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2020, 42 (06) : 555 - 559